Select a country to view results for that country.

Knowledge Centre - General, Journals, Publications & Research Articles

Linerixibat New Drug Application (NDA) accepted for review by the US FDA for cholestatic pruritus in patients with primary biliary cholangitis (PBC)

Published: 02 June 2025 by GSK press release

Abstract:

Application based on data from positive GLISTEN phase III trial

Read Article

Copyright © Therapists Africa 2025